期刊
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
卷 41, 期 5, 页码 623-630出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ejps.2010.09.002
关键词
Fenofibrate; Supersaturation; Oral absorption; Ordered mesoporous silica; SBA-15; MCM-41
资金
- K.U.Leuven Industrial Research Fund (IOF)
- Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT Vlaanderen)
- Flemish Government
- Research Foundation-Flanders (FWO-Vlaanderen)
The aim of the present study was to evaluate the effect of release rate from ordered mesoporous silica materials on the rate and extent of absorption of the poorly soluble drug fenofibrate. Three ordered mesoporous silica materials with different pore diameter (7.3 nm, 4.4 nm and 2.7 nm) were synthesized and loaded with fenofibrate via impregnation. Release experiments were conducted under sink conditions and under supersaturating conditions in biorelevant media, simulating the fasted and the fed state. Subsequently, all silica-based formulations were evaluated in vivo (rat model). The release experiments under sink conditions indicated a clear increase in release rate with increasing pore size. However, under supersaturating conditions (FaSSIF), the, pharmaceutical performance (in terms of both the degree and duration of supersaturation), increased with decreasing pore size. The same trend was observed in vivo (fasted state): the area under the plasma concentration-time profile amounted to 102 +/- 34 mu M h, 86 +/- 19 mu M h and 20 +/- 13 mu M h for the materials with pore diameter of 2.7 nm, 4.4 nm and 7.3 nm, respectively. The results of this, study demonstrate that a decrease in drug release rate - and thus, a decrease of the rate at which supersaturation is created - is beneficial to the absorption of fenofibrate. (C) 2010 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据